Vetting for transparency in Asian hedge funds

Investors are attracted by the alpha potential of hedge funds but can also be concerned over a lack of transparency. How does UBS Hedge Fund Solutions select the funds it invests in and how are those funds themselves managed?

11 Dec 2020

Hedge fund investing - vetting hedge funds for investors who demand transparency

Investors are attracted by the alpha potential hedge funds represent, but not as keen on what historically has been a lack of transparency. With Asian hedge funds newer to the scene than their peers in North America and Europe, it’s natural for investors to be curious about how UBS Hedge Fund Solutions (HFS) selects the funds it invests in – and how those funds are themselves managed.

Before he joined UBS HFS, Adolfo Oliete, was at a single-manager hedge fund. “We didn’t share anything at that time,” he says. “But I’ve seen an evolution in my time on this side of the fence in a multi-manager hedge fund. Our size and scale at UBS HFS help. Hedge funds view us as a trusted partner, so we do get all the transparency that we require for our own decision-making and on behalf of investors.”

Transparency is a bit like data in that once you have it, what matters most is what you do with it.  If a hedge fund holds 1,000 securities for example, it’s not especially relevant to have thorough insight into each of them. It’s more important to understand the holistic risk.

“We aim to understand the risks at a portfolio level, in terms of exposure and attribution of where the returns are coming,” says Oliete. “Conditional investments from us are dependent on that type of transparency, and that’s negotiated ahead of time. We’ve had to work very hard on that over the last five or six years in the region because transparency has been viewed as a bad thing for a long time – you don’t know where information is going, and you don’t really trust what people do with that information. Once the hedge funds understand who we are and what we do with that data, and how tightly we control that data, we receive transparency. And we provide our investors with a lot of aggregated risk and exposure metrics. Generally, we receive position level data from some managers, but in most cases we collect data on the top positions that have the potential to move the needle.”

Oliete says he and his team have a bias to invest in managers that are locally-based, mostly in Mainland China where they pursue substantive research themes bolstered by visits to companies and factories – in other words, hedge funds that really dig into the weeds.

“We focus on managers that have large research capabilities and ideally are based in Mainland China so they can easily access those companies,” he says. “We’re underwriting the strategy, portfolio and risk management, and also the people at the hedge fund and how knowledgeable they are. We meet with the management, analysts – we want to know the whole team at the hedge fund.”

We don’t shy away from saying no to a hedge fund if we’re not comfortable with some of the principals, or if they’re unwilling to implement what we suggest is necessary for them to grow into the institutional space.

Benno Klingenberg-Timm,
Head, Global Sovereign Markets, APAC,

Educating hedge funds

As the number of hedge funds in Asia and Mainland China increases, Oliete and his team find themselves investing time in educating the principal players at the funds on matters such as the operating infrastructure of the firm and running a business beyond investments.

“We want to be certain that the funds are set up for success as companies and capable of handling the sophisticated needs of institutional investors, which is something that has taken a little bit of time in the region,” Oliete says. “Sometimes when you look at the hedge fund industry in Asia as a whole, it’s obvious that it has developed very quickly. There’s still work to be done. However, funds appreciate our partnership because we provide that expertise and share the necessary nuance of what it takes to appeal to institutional investors, and what those investors expect in a fund.”

Oliete is impressed with the talent pool at Asian hedge funds, but his team does expect a fund to accept that there is room for improvement when it is pointed out to them, and will commit to that improvement over time if they want to work with UBS HFS.  

“It’s important that we not compromise very high bar that we have set for operational due diligence at UBS HFS,” says Klingenberg-Timm. “We don’t shy away from saying no to a hedge fund if we’re not comfortable with some of the principals, or if they’re unwilling to implement what we suggest is necessary for them to grow into the institutional space.”  

Within UBS HFS, a separate team focuses on operational diligence in order to avoid conflict. “If I really like something from an investment perspective, I cannot be the one to judge the hedge fund’s infrastructure, operational controls, and so forth. It doesn’t matter what I think – if the hedge fund doesn’t pass the standards set by that team, we don’t invest at that time. We don’t necessarily walk away – we help them try to fix it before so we can invest without compromising our standards.”

“The desire for hedge funds to go with a partner that applies global standards when it comes to due diligence and best practices matters enormously,” says Klingenberg-Timm. “I think that’s one reason why investors will rely more on partners like us to actually invest into hedge funds and in Asia. It’s a huge market, but some of the standards are still developing because these funds have not been around for 20 years. Maybe not even for 10 years, and global institutional standards are not always applied from the start. Sometimes they can’t be because the asset base is simply not big enough to warrant such a setup. We understand that, but we need to see that the willingness is there to reach the institutional level that we would like to see in any global fund we invest in.”

The give and take with hedge funds, and the willingness to educate willing students as it were, is “probably what some investors will be looking at when they decide that they’d rather access the opportunity in Asia through us rather than working directly with the hedge funds,” says Klingenberg-Timm.

In fact, we have some large sovereign clients in APAC that do know where to find these funds, but they do not want to do the operational due diligence on their own. They’d rather defer to a team with a global platform, and with people who do this every day all around the world.

This is an extract of the article “In search of alpha: Asian hedge funds in focus” which first appeared on Institutional Investor.

In search of alpha: Asian hedge funds in focus

When you look at the alpha per unit of risk that you can capture in a good Asian hedge fund manager, it’s far better than what you’ll see anywhere else.

In some of our portfolios, around 40% of our equity allocation is directed toward Asia.

Bruce Amlicke
Chief Investment Officer, UBS Hedge Fund Solutions

UBS Hedge Fund Solutions

UBS Hedge Fund Solutions (HFS) offers a wide range of hedge fund solutions including commingled products and customized discretionary products, as well as portfolio advisory and strategic advisory services. The firm is headquartered in Stamford, Conn., with additional offices in New York, London, Zurich, Hong Kong, San Francisco, Shanghai, Tokyo, and Krakow.

As of 1 October 2020, HFS currently manages approximately USD 35.9 billion and has allocated over USD 275.5 billion since inception. UBS Hedge Fund Solutions (HFS) was founded in 1994 and is a wholly owned subsidiary of UBS Asset Management (Americas) Inc.

HFS is the second largest hedge fund manager globally (Source: HFM InvestHedge Billion Dollar Club, published March 2020).

Subscribe now

Perspectives matter. Tune in to our insights.

Singapore Retail Investors


This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2021 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.


More insights